Sanna M E Iivanainen

12PUBLICATIONS
29CO-AUTHORS
Preventative health careCancer therapy (excl. chemotherapy and radiation therapy)Data structures and algorithmsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 20, 2026
Effect of Lung Cancer Screening, Smoking Cessation, and Cessation Smartphone App to Health-Related Quality of Life Among Heavy Smokers: Randomized Controlled Trial.

Antti Kurtti, Sanna Iivanainen, Riitta Kaarteenaho

|Jul 12, 2025
Concomitant Use of Analgesics and EGFR TKIs in Lung Cancer Patients: Outcomes and Perspectives From a Finnish Retrospective Register-Based Study.

Laura S Puuniemi, Sanna M E Iivanainen, Martti Arffman

|Mar 31, 2025
Development of a Comprehensive Decision Support Tool for Chemotherapy-Cycle Prescribing: Initial Usability Study.

Sanna Iivanainen, Reetta Arokoski, Santeri Mentu

|Mar 17, 2025
Association of anti-PD-(L)1 treatment duration to efficacy in advanced solid tumors: a single center retrospective study.

Saara Kuusisalo, Sanna Iivanainen, Jussi P Koivunen

|Nov 07, 2023
Treatment outcomes of non-small cell lung cancers treated with EGFR tyrosine kinase inhibitors: a real-world cohort study.

Otto Manninen, Laura Puuniemi, Sanna Iivanainen

|Oct 18, 2023
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer.

Abdul Rafeh Naqash, Justin D McCallen, Emma Mi

Pageof 2

Frequent Collaborators

7 joint publications

Jussi Pekka Koivunen

2 joint publications

Jussi Ekstrom

2 joint publications

Johannes Ammann

2 joint publications

Riitta L Kaarteenaho